Reliable noninvasive methods are needed to monitor cell engraftment and graft survival after hepatocyte transplantation. Superparamagnetic iron oxide nanoparticles (SPIOs) have been shown to accumulate in various types of cells, and are currently the labeling agent of choice for cellular magnetic resonance imaging (MRI). However, for successful clinical translation to hepatocyte transplantation, it is important that hepatocytes maintain their viability and synthetic function after labeling. In this study, primary human hepatocytes were incubated with increasing concentrations of clinical grade SPIOs for different time intervals. SPIOs uptake was confirmed by light and fluorescence microscopy, and intracellular iron content quantified by a colorimetric ferrozine-based assay. Studies were performed to determine if labeling affected cell viability and function. Intracellular iron concentrations increased in a time-and dose-dependent manner after incubation with SPIOs. Labeling had minimal short-term effects on cell attachment and mitochondrial function. However, exposure of hepatocytes to SPIOs resulted in a dose-and time-dependent reduction in protein synthesis. Cell labeling for 16 h had no significant effect on hepatocyte-specific function, but longer periods of incubation resulted in a dose-dependent decrease in albumin production. Hepatocytes incorporated SPIOs at sufficient levels for in vitro detection on a 7-T MRI imaging system, with a minimum of 2,000 SPIOlabeled cells/µl detected by a decreased T2 relaxivity compared to controls. Intrasplenic transplantation of human hepatocytes labeled with 50 µg Fe/ml of SPIOs was performed in nonobese diabetic/severe combined immune deficiency (NOD-Scid) mice. Recipient livers showed a clear decrease in signal intensity on T2*weighted MR images when compared to controls, allowing detection of hepatocytes. With further experiments to optimize the conditions for labeling human hepatocytes, it should be possible to apply this technique to track hepatocyte transplantation in patients with liver disease. 963 964 PUPPI ET AL.
INTRODUCTION
has yet been achieved. This limited clinical efficacy might be the result of substantial hepatocyte loss after transplantation. Potential causes for this initial cell loss With recent advances in the field of cell therapy, there has been an increasing interest in the use of mag-are apoptosis (13) , tissue factor-dependent activation of the coagulation cascade (39) , and/or acute humoral re-netic resonance imaging (MRI) to track and monitor transplanted cells and cellular processes in vivo (27) . jection of transplanted hepatocytes (17) . The early phases of HT are critical and initial monitoring of graft function Hepatocyte transplantation (HT) is one of the cell therapies that would benefit from this technique (32) . Trans-is usually indirect, determined by the patient's metabolic improvement, or dependent on analysis of multiple inva-plantation of hepatocytes has been studied as a therapeutic alternative or as a bridge to orthotopic liver sive liver biopsies (23, 38, 40) . However, metabolic changes may take a few weeks to become evident and can be transplantation (9, 12) , and although clinical trials in patients with acute liver failure (ALF) and liver-based met-difficult to assess in patients with ALF due to frequent concurrent multiorgan failure. To date, scintigraphic im-abolic disorders have proven HT safe, no complete and sustained correction of liver disease by this technique aging using indium-111-labeled hepatocytes has been the only method reported for short-term noninvasive using a modified two-step collagenase perfusion technique (24) and hepatocytes were purified by low speed monitoring of clinical HT (4). This represents a major limitation for the development of clinical HT. centrifugation at 50 × g for 5 min at 4°C. The isolated cell fraction used for in vitro studies was >90% hepato-MRI offers high anatomical detail, combined with the possibility of serial imaging, but requires an efficient cytes by morphological and immunocytochemical analysis. Briefly, cytospins were fixed in acetone and endoge-labeling method with suitable contrast agents before transplantation to allow tracking of grafted cells within nous peroxidase blocked with 0.3% H 2 O 2 in methanol for 15 min. Cells were blocked and permeabilized with the host tissue (27) . Although gadolinium-based agents potentially provide an unequivocal positive contrast, 5% fetal calf serum (FCS) in Tris-buffered saline containing 0.1% Triton X-100 (Sigma-Aldrich, UK) for 30 they have been found to increase reactive oxygen species (ROS) in neural stem cells and to impair the repair min, followed by incubation with goat anti-human antibody against albumin horseradish peroxidase-conjugated process in stroke-lesioned brains (6, 26) . In contrast, superparamagnetic iron oxide nanoparticles (SPIOs) are (dilution 1:200; Bethyl Laboratories, USA) and color development using diaminobenzidine (KPL, USA). HeLa the most common class of contrast agents used for cellular labeling and imaging, and various types of cells have cells were used as negative controls. The mean cell yield of isolated hepatocytes was 4.4 ± 0.74 × 10 6 cells per been efficiently labeled and tracked in vivo (8, 37) . It is generally accepted that iron oxide particles are well gram of liver tissue with 71 ± 2% viability, as determined by the trypan blue (0.4%) exclusion method. Col-tolerated in vivo. After IV administration, most SPIOs are rapidly cleared from the blood by reticuloendothelial lagen-coated tissue culture plates were seeded with hepatocytes (16 × 10 4 viable cells/cm 2 ) and cultured at system (RES) cells of the liver, spleen, lymph nodes, and bone marrow (41) , appearing as regions of low sig-37°C in 95% O 2 /5% CO 2 . Standard hepatocyte culture medium consisted of Williams' E medium (WEM), sup-nal intensity (hypointense) on T2*-and T2-weighted MRI sequences, creating a negative contrast. Once inter-plemented with 10 mM HEPES (Cambrex, UK), 10% heat-inactivated FCS, 2 mM L-glutamine (Invitrogen, nalized by cells, SPIOs are compartmentalized within the lysosomes, metabolized, and recycled in the normal UK), 0.1 µM dexamethasone, 0.1 µM insulin, penicillin (50 IU/ml), and streptomycin (50 µg/ml) (Sigma-Ald-iron pool (7) .
In order to be detected by MRI, cells of interest must rich, UK). Plating efficiency was determined by measuring protein content (22) of attached cells and that of the be labeled with relatively large amounts of contrast agent. In addition, slowly dividing cells and those that initial number of viable cells seeded, and the mean value was 54 ± 4%. lack substantial phagocytic activity require incubation with high concentrations of SPIOs for extended periods In Vitro Hepatocyte Labeling of time for an efficient labeling. While it has been reported in several studies that SPIO labeling does not ap-SPIO nanoparticles, Endorem (Guebert, France), a clinically approved liver MRI contrast agent, was used pear to affect viability or other cellular properties (1, 15, 28) , some recent reports have shown that iron oxide par-to label cells. This contrast agent consists of dextrancoated iron oxide particles (80-150 nm in size) and has ticles can have a dramatic effect upon cell behavior and morphology (3,21,29,31). As a result, there is a need for a total iron content of 11.2 mg/ml (41) . After overnight incubation, culture medium was replaced by fresh me-detailed studies on the biological effects of SPIO labeling, which may vary according to different cell types.
dium containing SPIOs (0-150 µg Fe/ml). For labeling efficiency and viability studies, cells were incubated Here we examined and quantified the specific effects that clinically approved SPIOs (Endorem) have on pri-with SPIOs for 2, 4, 6, 16, and 24 h. For all other experiments, SPIOs were included in the culture medium for mary human hepatocytes in short-and long-term cultures, evaluate whether labeled cells retain their ability 16 and/or 24 h. Medium containing SPIOs was then discarded and cells were washed three times with phos-to perform normal cellular functions, and if they can be detected by MRI.
phate-buffered saline (PBS) to remove free particles. For longer term cultures, after 16 h of labeling stan-MATERIALS AND METHODS dard medium containing SPIOs was replaced by WEM Human Hepatocyte Isolation and Culture supplemented with 0.2 mg/ml bovine serum albumin (BSA), 20 µg/ml linoleic acid, 2 µg/ml linolenic acid, Hepatocytes were isolated from 13 liver resection tissues (median donor age 65 years; range 55-73 years) 2.45 µg/ml cAMP, 0.1 µM dexamethasone, 0.01 IU/ml prolactin, 0.06 ng/ml ethanolamine, 1 µg/ml glucagon and 13 unused donor liver segments/lobes (42 years; 13-59 years). All tissues were consented for research in (Sigma-Aldrich, UK), 9 ml/L insulin-transferrin-selenium-X 100x supplement (Gibco, UK), 20 ng/ml hepa-accordance with the Research Ethics Committee of King's College Hospital. Cell isolation was carried out tocyte growth factor, 50 ng/ml epidermal growth factor LABELING OF HEPATOCYTES WITH SPIOs 965 (Peprotech, USA), 2 mM L-glutamine, 10 mM HEPES, were performed in duplicate and results were expressed as pg Fe/cell. 50 IU/ml penicillin, 50 µg/ml streptomycin, and 3 µl/ ml Fungizone (Invitrogen, UK). Medium was replaced Viability and Function every 48 h during the first week and every 72 h thereafter (11) .
Cytotoxicity assays were performed on hepatocytes seeded onto collagen-coated 96-well plates in eight rep-Analysis of SPIOs Uptake licates and repeated at least three times for each time point. Prussian Blue Staining and Immunofluorescence.
Sulphorhodamine (SRB) Cytotoxicity Assay. This Uptake of SPIOs was visualized using Prussian blue assay was used to determine the effects of SPIOs on (PB) staining and anti-dextran immunostaining. After lacell attachment (25) . After incubation with SPIOs, cell beling, cells were washed with PBS and detached accultures were washed with PBS and fixed with 50% tricording to Funaki et al. with some modifications (14) . chloroacetic acid solution. Wells were rinsed with water Briefly, cell cultures were incubated with PBS solution and cells stained with 0.4% SRB solution. Excess of dye containing ethylene diamine tetraacetic acid (EDTA) was removed by washing with 1% acetic acid. Protein-[1.86 g/L of EDTA 2Na, 0.45 g/L of glucose, 2.38 g/L bound dye was solubilized by using Tris-base unbufof soybean trypsin inhibitor (Sigma-Aldrich, UK) at pH fered solution. Plates were read at 550 nm using a mi-7.4] for 10 min at 37°C, washed twice with PBS, and croplate reader. incubated for a further 10 min with 0.05% collagenase MTS Assay. Mitochondrial dehydrogenase activity of solution containing 50 mg/L of DNase and 2 mM of labeled hepatocytes was assessed using the CellTiter CaCl 2 . Detached cells were collected, centrifuged at 96 AQ ueous Non-Radioactive Cell Proliferation Assay least twice for 3 min at 50 × g at 4°C, and resuspended (MTS) (Promega, UK) according to the manufacturer's in WEM. Cells were then transferred onto glass slides instructions. Absorbance of formazan produced was and fixed with 4% paraformaldehyde (PFA). For PB measured using a microplate reader at 490 nm. Results staining, cells were incubated for 20 min with 2% potaswere expressed as percentage of controls. sium ferrocyanide in 6% HCl. Slides were washed with PBS and counterstained with nuclear fast red (Sigma-Protein Synthesis. Incorporation of [ 14 C]leucine was Aldrich, UK).
determined after labeling cells with SPIOs for different Immunofluorescence staining for dextran was perperiods of time. Briefly, 200 µl of culture medium containformed on cells cultured in collagen-coated chamber ing 0.1 µCi L-[U-14 C]leucine (Amersham, UK) was added slides. After three washes with PBS, cells were fixed, per well and plates were incubated for 24 h. Cells were permeabilized, and incubated with a FITC-conjugated then harvested onto glass fiber membranes using a cell mouse monoclonal anti-dextran antibody (StemCell harvester (FilterMate TM , Packard Instruments, UK). Radio-Technologies, USA) at a 1:10 dilution for 1 h at room activity was counted using a β-counter (MATRIX TM 9600 temperature (RT). Cells were mounted in Vectashield Direct β Counter, Packard Instruments, UK) and results medium containing DAPI (4′-6-diamidino-2-phenylinwere expressed as percentage of 14 C incorporation of dole) nuclear counterstain (Vector Laboratories, USA). controls without SPIO labeling. Slides were visualized using a Zeiss Axio-Imager Microscope equipped with an Axiovision 4.5 digital acqui-Specific Metabolic Functions sition system.
For the assays described below, cells were cultured in collagen-coated 24-well plates. Measurements were Cellular Iron (Fe) Content. Intracellular iron uptake was determined using a colorimetric ferrozine-based performed in duplicate, and repeated at least three times. Results were normalized against the protein content of assay (34). After labeling, cells were detached, washed with PBS, and lysed with 50 mM NaOH. One-hundred each well (22) . Albumin and transferrin concentrations were mea-microliters of the cell lysate was mixed with 10 mM HCl (100 µl) and equal volumes of 1.4 M HCl and 4.5% sured in culture supernatants after 16 and 24 h of incubation with SPIOs using human albumin and transferrin (w/v) KMnO 4 (100 µl), and incubated at 60°C for 2 h. Thirty microliters of iron detection reagent (6.5 mM fer-enzyme-linked immunosorbent assay (ELISA) kits (Bethyl Laboratories, USA), according to the manufactur-rozine, 6.5 mM neocuproine, 2.5 M ammonium acetate, and 1 M ascorbic acid) (Sigma-Aldrich, UK) was added er's recommendations. Results were expressed as µg albumin or transferrin/mg cell protein. Urea formation to each tube. Absorbance of samples was measured at 550 nm on a microplate reader (Dynex MRX, Dynex was measured in the culture supernatants using the colorimetric QuantiChrom TM assay kit (BioAssay Systems, Technologies Ltd., UK) and compared to a standard curve prepared using FeCl 3 (0-300 µM). Cytochrome P450 (CYP1A1/2) activity after 24 h of DCFDA to green fluorescing CM-DCF indicates production of organic hydroperoxides that are formed after labeling was assessed using the ethoxyresorufin O-deethylation method (10) . Briefly, 8 µM of 7-ethoxyresoru-lipid peroxidation. After 16 h of labeling, cells were incubated with 10 µM of CM-H 2 DCFDA for 30 min at fin substrate and 10 µM of dicumarol were added to each well and incubated at 37°C for 30 min. To include 37°C, washed with PBS, and harvested by scraping with a rubber policeman. A total of 10,000 cells were ac-the formation of resorufin conjugates, culture supernatants were incubated with β-glucuronidase and arylsulfa-quired on a FACSCalibur and analyzed using CellQuest software. The results were expressed as a percentage of tase at 37°C for 2 h. The reaction was stopped by addition of ethanol and fluorescence was read at 530 nm the mean fluorescence intensity (MFI) of corresponding controls. excitation/590 nm emission, using a fluorescence micro- 
Hepatocyte Transplantation in Mice
tion. To determine the MRI detection threshold hepatocytes were labeled with 50 µg Fe/ml of SPIOs. Nonla-Animals. Nonobese diabetic/severe combined imbeled cells (20,000/µl) and different densities of labeled mune deficiency (NOD-Scid) mice (Harlan, UK) of [6] [7] [8] cells (20-20,000/µl) isolated from the same donor tissue weeks of age and weighing between 20 and 30 g were were resuspended in liquid 6% gelatin (w/v) (Sigmaused as hepatocyte recipients. The animals were allowed Aldrich, UK) and transferred to PCR tubes. The mixture to acclimatize for at least 1 week prior to HT. Food and was allowed to solidify rapidly at 4°C to prevent clumpwater were available ad libitum. All procedures were in ing of the cells in the gelatin. In order to stabilize the accordance with the UK Animals (Scientific) Procedures tubes and also to avoid artifacts from the surrounding Act of 1986 and the ethical review process of King's air during the MRI scanning, the tubes were placed in a College London.
4% agarose phantom. All MRI experiments were per-Hepatocyte Labeling and Transplantation. Cells were formed on a 7-T 30-cm-bore horizontal Varian magnetic prepared for transplantation by labeling with SPIOs at resonance system (Varian Inc., UK) using a custom-50 µg Fe/ml for 16 h. Cells were washed three times made quadrature coil driven by VNMRJ 2.2.b software. with PBS and detached as described above. Detached A multislice spin-echo imaging sequence was used to cells were washed twice by centrifugation at 50 × g for acquire T2-weighted images [repetition time (TR) = 3 min, counted, and resuspended in Roswell Park Me-2,000 ms, 8 echo times = 10, 20, 30, 40, 50, 60, 70, 80 morial Institute (RPMI)-1640 medium. Animals received ms, 2 averages, field of view (FOV) = 50 × 50 mm, slice 2.5 × 10 6 SPIO-labeled (n = 3) or nonlabeled (n = 3) huthickness = 2 mm, matrix size = 256 × 256]. Relaxivity man hepatocytes in 500 µl of medium into the spleen.
measurements were based on these images that were A control group (n = 3) consisted of intrasplenic vehicle used to calculate T2 maps using VNMRJ 2.2.b. injection of RPMI-1640 medium alone. Animals were an-For the MRI of the mice, a multislice spin-echo imesthetized by isoflurane inhalation. The lower pole of the aging sequence was acquired for the calculation of T2 spleen was isolated via a subcostal incision. The cell susmaps (TR = 2,800 ms, 8 echo times = 10, 20, 30, 40, 50, pension was injected using a 25-gauge needle with he-60, 70, 80 ms, 4 averages). T2*-weighted images were mostasis secured by ligation of the tip of the spleen. After acquired using a multislice gradient-echo sequence (TR = 2 h, the animals were anesthetized with isoflurane and 500, flip angle = 15°, 6 averages). For the animal experiperfused through the heart with heparinized saline (5,000 ments, the FOV was 30 × 30 mm, with 0.6-mm-thick IU/L), followed by perfusion of the whole animal with slices, and a 192 × 192 matrix size. 4% (PFA) in PBS to fix the tissues. The livers were evalu-Statistical Analysis ated by both MRI of the mice and liver tissue analysis.
Results are presented as mean ± SEM. Differences Liver Histology. Transplanted human cells were debetween labeled and nonlabeled (control) cells were tected on 5-µm-thick, PFA-fixed, paraffin-embedded tistested using either the unpaired Student's t-test or ANOVA sue sections using human serum albumin immunohistowith repeated measurements, with comparisons between chemistry and PB staining for iron as described above.
groups performed by the least significant difference (LSD) test. A value of p ≤ 0.05 was considered statisti-Relaxivity Measurements and Magnetic Resonance cally significant.
Imaging (MRI)
RESULTS Based on the results of the cytotoxicity assays, hepa-Analysis of Labeling Efficiency tocytes were labeled for 16 h with 0-50 µg Fe/ml of SPIOs and then scanned (20,000 cells/µl) to determine Incubation of hepatocytes with SPIOs resulted in incorporation of the contrast agent, as demonstrated by PB the optimal contrast agent concentration for MRI detec- Relaxometry of cells labeled with 50 µg Fe/ml for 16 h, embedded in 6% gelatin, and scanned using a 7-T MRI system. Depending on the cell concentrations, SPIO-labeled cells shortened T2 relaxation times by (A) 14%, 48%, and 84% (for 2,000, 4,000, and 20,000 cells/µl, respectively) compared to corresponding control cells at day 1 after labeling, and (B) by 35%, 51%, and 84% at day 4. staining for iron ( Fig. 1A) , but the uptake was heteroge-Effects of Iron Incorporation on Cell Viability neous. Nonlabeled hepatocytes did not show any stainable iron (Fig. 1B) . Incorporation of the contrast agent After incubation with SPIOs, the number of attached cells measured by the SRB assay at different time inter-nanoparticles was confirmed by anti-dextran immunofluorescent staining (Fig. 1C) . Intracellular iron concen-vals was similar to that in controls ( Fig. 2A) . The mitochondrial activity was increased in cells labeled for up trations increased in a time-and dose-dependent manner after incubation with SPIOs up to 18.5 ± 3.4 pg Fe/cell to 6 h (p < 0.05). A significant decrease in formazan formation from MTS was only observed after cell incu- (Fig. 1D) . Hepatocytes were labeled with 25 µg Fe/ml of SPIOs for 16 h and then maintained in culture for up bation with 150 µg Fe/ml for ≥16 h (16 h = 82.2 ± 6.0%, p < 0.001; 24 h = 86.0 ± 3.1%, p < 0.01) compared to to 8 days. At day 8, intracellular iron concentration was 7.9 ± 0.7 pg Fe/cell, showing retention of the label.
the corresponding controls (Fig. 2B ). However, a signif-icant dose-and time-dependent reduction in [ 14 C]leucine cell protein, p < 0.001) compared to control (6.6 ± 1.0 µg albumin/mg cell protein). Longer term cell cultures incorporation by hepatocytes was evident after SPIO labeling, decreasing up to 60% after 24 h of labeling with after SPIO labeling demonstrated a dose-dependent decrease in albumin production (p < 0.05) at day 4 with 150 µg Fe/ml compared to controls (p < 0.05) (Fig. 2C) .
subsequent recovery at day 8 and 14 in cell cultures la-Effects on Liver-Specific Function beled with ≤50 µg Fe/ml to values comparable to control levels (Fig. 3B ). After 16 h of incubation with SPIOs, albumin production in labeled cells was comparable to correspond-No significant difference in urea production between SPIO-labeled cells and controls was observed on day ing controls (Fig. 3A) . Longer incubation times (24 h) with SPIOs resulted in a decrease in albumin production 1 (Fig. 3C ). Subsequently, urea synthesis progressively decreased during the culture period up to 14 days in all (50 µg Fe/ml = 4.2 ± 0.4, p < 0.01; 100 µg Fe/ml = 3.3 ± 0.4, p < 0.001; 150 µg Fe/ml = 3.3 ± 0.4 µg albumin/mg groups studied, particularly in cells labeled with ≥100 µg Fe/ml, although this reduction was not statistically mals transplanted with nonlabeled hepatocytes showed cells expressing human albumin, which did not stain for significant (Fig. 3D) .
The ability of labeled cells to synthesize transferrin iron (Fig. 5E ). Cells expressing human albumin were absent in livers transplanted with vehicle-alone injection was not significantly affected after 16 and 24 h of incubation with SPIOs compared to controls (Fig. 3E ).
( Fig. 5F) . Human liver and mouse liver were used as positive and negative controls, respectively, for human CYP1A1/2 activity after 24 h of labeling was similar to control levels at all concentrations studied (Fig. 3F) .
albumin immunoperoxidase staining (Fig. 5G, H) .
DISCUSSION

ROS Production
An increase in intracellular unbound iron is known to This study has shown that human hepatocytes incorporate clinically approved dextran-coated SPIOs, which induce generation of a wide range of ROS, based on the Fenton and Haber-Weiss reactions. No significant could be detected by MRI after hepatocyte transplantation in mice. SPIOs had no adverse effects on cell at-changes in ROS production were observed in cells within 16 h after labeling ( urea and transferrin synthesis, and CYP1A1/2 activity In Vitro MRI and Detection Threshold were preserved after labeling. However, longer term culture of the cells with SPIOs demonstrated that, at higher SPIO-labeled hepatocytes produced a dose-dependent decrease in T2 relaxivity compared to nonlabeled cells.
concentrations, labeling affected albumin and urea production. In order to determine the detection threshold of this method and to establish a correlation between number
There are previous reports of adverse effects of SPIOs on other types of cells in culture. Human fibro-of hepatocytes and change in T2 relaxivity, increasing numbers of SPIO-labeled cells (from 20 to 20,000 cells/ blasts exposed to 50 µg/ml of SPIOs for 48 h showed an increase in apoptosis and cell death, aberrations in µl) were imaged at day 1 and 4 after labeling. T2 relaxivity was dependent on the number of labeled cells. At cell morphology, and decreased cell motility (3). Incubation with iron oxides with an anionic surface coating day 1, concentrations of 2,000, 4,000, and 20,000 SPIOlabeled cells/µl induced a decrease of 14%, 48%, and resulted in dose-dependent cytotoxicity and cell detachment, increased cytoskeletal disruption, and reduced 84%, respectively, on T2 relaxivity compared to nonlabeled cells (Fig. 4A) . At day 4, the changes in T2 relax-ability of pheochromocytoma cells to appropriately respond to nerve growth factor (31). Other adverse effects ation times were still evident and concentrations of 2,000 labeled cells resulted in a T2 relaxivity change of reported included inhibition of proliferation (5) and impairment of differentiation of mesenchymal stem cells 35% (Fig. 4B ).
into chondrogenic lineage (21) . Hussain et al. (18) pre-MRI Detection of Transplanted Cells sented data on the toxicity of various metal oxide nanoand Histological Assessment particles on immortalized rat hepatocyte cultures and showed a cytotoxic effect of iron oxides at 250 µg/ml SPIO-labeled human hepatocytes were transplanted intrasplenically into NOD-Scid mice and animals were dose. Assessing potential ill effects of contrast agents in vitro is essential as minor changes might be indicative scanned 2 h after the procedure. Labeled cells clearly induced a decrease in signal intensity in the liver on of agents interfering with cellular repair processes as has previously been demonstrated for a gadolinium-based T2*-weighted images, showing that labeled cells translocated throughout the liver and can be detected by MRI agent (6, 26) . The mechanism of incorporation of SPIOs into cells (Fig. 5A) . To determine the contribution of SPIOs to the detection of transplanted human hepatocytes, animals is probably by fluid-phase endocytosis. Our results demonstrated that incorporation of SPIOs by liver cells was were transplanted with nonlabeled hepatocytes and vehicle only injection. In these animals, transplanted cells nonsaturable in the range of concentrations and incubation times tested. However, PB staining showed a het-did not change the MRI signal ( Fig. 5B, C) . Human albumin immunoperoxidase and PB staining performed on erogeneous SPIOs uptake with no stainable iron in some of the cells. Similar uptake patterns have been reported liver sections of mice transplanted with SPIO-labeled cells showed the presence of clusters of cells expressing in other studies that used iron oxide particles to label cells (28) . human albumin, which also stained for iron located mainly within the portal spaces (Fig. 5D ). Stained cells
The retention of the contrast agent within the cells, along with preservation of cellular viability and func-had the typical morphology of hepatocytes. Liver of ani-tion, are essential to reliably monitor the fate of cells in zene polymer shell. Shapiro et al. reported spontaneous hepatocyte uptake of MPIOs and in vivo single cell de-vivo for a period of time after transplantation. In this respect iron could be detected in labeled cells by MRI tection after intrasplenic injection of labeled hepatocytes in a murine model (35) . Primary human hepatocytes also after 4 days and was still quantifiable in the cells after 8 days of culture. However, it is possible that iron did showed a fast uptake of MPIOs in culture, with no effects on viability or function, while being readily detected not remain in the form of nanoparticles in the cells. The core of SPIOs consists of magnetite (Fe 3 O 4 ) and maghe-by MRI (33) . However, these particles are nonbiodegradable and thus may present problems for translation mite (γFe 2 O 3 ) stabilized by a dextran coating (8) . Previous reports in other cells have shown that the low pH of to clinical use. The use of clinically approved SPIOs for imaging transplanted hepatocytes, as in the current endosomes/lysosomes, as well as the presence of endogenous iron chelates, can solubilize the iron core within study, will make it easier for clinical application. The biodegradable properties of these particles make this ap-a few days, releasing ferric iron [Fe(III)] into the cytoplasm (2,36). The colorimetric ferrozine-based assay proach safe, with no expected long-term side effects, although there is the disadvantage of possible loss of de-used in this study cannot differentiate the form of iron, as Fe(III) is reduced into ferrous iron [Fe(II)] with tectability of the labeled cells. This technique should allow detection of cell biodistribution and/or loss of ascorbic acid. Intracellular iron concentration levels are controlled by both cellular transferrin receptors and cy-cells at an early stage after transplantation to allow appropriate intervention. toplasmic ferritin. In the presence of H 2 O 2 , free iron catalyzes formation of ROS. When ROS levels exceed the In summary, this study has defined conditions for labeling human hepatocytes in culture with SPIOs at suffi-antioxidant capacity of the cells, it can cause cell damage through oxidation of proteins, peroxidation of lipid cient levels for MRI detection, without significant deleterious effects. Labeled hepatocytes transplanted into the membranes, and DNA damage (20, 30) . In this study, exposure of cells to SPIOs for 16 h did not result in an liver via the spleen were clearly detected in mice on T2*-weighted MRI sequences soon after transplantation. increase in ROS formation, suggesting that nanoparticles were still intact at this point.
With further experiments to optimize the conditions for labeling human hepatocytes, particularly to obtain more SPIOs create magnetic field inhomogeneity and dephasing of the transverse relaxation, causing a decrease uniform labeling of cells, it should be possible to develop this technique for use in hepatocyte transplanta-in signal intensity on T2-and T2*-weighted MRI, which gives the hypointense images. However, if nanoparticles tion in patients with liver disease. are broken down and free Fe(III) is released into the specific contrast agent, so that particles released from REFERENCES damaged hepatocytes will be taken up by Kupffer cells, initially labeling these cells followed by rapid degrada- sists of a magnetite core in an inert styrene-divinyl ben-
